Futurity April 17, 2024
Shantell Kirkendoll-Duke

A new mathematical model offers hope for better prediction and treatment of Alzheimer’s disease, researchers report.

Most mathematical models of Alzheimer’s are theoretical, focusing on short term molecular and cellular-level changes that cannot be measured in patients.

However, researchers at Duke University School of Medicine and Pennsylvania State University have used real-world data from over 800 people with varying cognitive abilities, to develop the Alzheimer’s Disease Biomarker Cascade (ADBC) model.

This personalized approach goes beyond traditional diagnostic methods by incorporating an individual’s own biological markers to predict their disease progression.

The research appears in the Journal of the Prevention of Alzheimer’s Disease.

Subjects were enrolled in the Alzheimer Disease Neuroimaging Initiative (ADNI), a multinational longitudinal study following subjects from normal...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Health System / Hospital, Pharma / Biotech, Provider
Why hospital executives think Walmart Health failed
Piedmont aims to expand after Wellstar closure
Tenet Healthcare pushes to grow ASC footprint in 2024
AAMC study examines the impact of health care consolidation in states
Tenet adds 45 ASCs, sells 9 hospitals in Q1

Share This Article